Video

Treating opioid addiction in emerging adults

Current Psychiatry. 2016 June;15(6)
By
Marc J. Fishman, MD
Author and Disclosure Information

Marc J. Fishman, MD, explains that the standard of care for young adults includes relapse-prevention medications—buprenorphine, extended-release naltrexone, even methadone—in a developmentally specific approach.

 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

VIDEO: How to personalize pain management in era of opioids
MDedge Psychiatry
HIV PrEP would help infected drug users, but not cost-effectively
MDedge Psychiatry
Varenicline, bupropion not tied to significant increase in neuropsychiatric events in smokers
MDedge Psychiatry
FDA panels recommend expanding REMS, requiring prescriber education, for ER/LA opioids
MDedge Psychiatry
FDA takes more steps to keep kids off tobacco products
MDedge Psychiatry
Tailor Alcoholics Anonymous principles for clinical practice, experts say
MDedge Psychiatry
Methadone programs allowed pregnancy outcomes similar to nonusers
MDedge Psychiatry
VIDEO: Post legalization, what effect is recreational marijuana use having on children?
MDedge Psychiatry
Study shines light on ‘invisible epidemic’
MDedge Psychiatry
Benzodiazepines might succeed as monotherapy for cannabinoid-induced catatonia
MDedge Psychiatry